Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Belimumab”

Showing 20 of 0 results

Not applicableUnknownNCT05588830
What this trial is testing

The Efficacy and Safety of Telitacicept and Belimumab in Active Lupus Nephritis in the Real World: a Prospective Cohort Study

Who this might be right for
Lupus NephritisBelimumabTelitacicept
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 60
Not applicableStudy completedNCT01858792
What this trial is testing

A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) Studies

Who this might be right for
Lupus Erythematosus, Discoid
Human Genome Sciences Inc., a GSK Company 1
Testing effectiveness (Phase 2)UnknownNCT01142011
What this trial is testing

Belimumab in Treating Symptomatic Waldenstroms Macroglobulinaemia

Who this might be right for
Symptomatic Waldenstroms Macroglobulinaemia
Cancer Trials Australia 15
Testing effectiveness (Phase 2)Study completedNCT02284984
What this trial is testing

Synergetic B-cell Immodulation in SLE

Who this might be right for
Lupus Erythematosus, Systemic
Leiden University Medical Center 16
Large-scale testing (Phase 3)UnknownNCT05020782
What this trial is testing

The BeLimumab Antiphospholipid Syndrome Trial (BLAST)

Who this might be right for
Antiphospholipid Syndrome
University of Turin, Italy 15
Post-approval studies (Phase 4)Study completedNCT01632241
What this trial is testing

Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Human Genome Sciences Inc., a GSK Company 503
Not applicableNot Yet RecruitingNCT07069972
What this trial is testing

A Prospective Comparative Study Involving Multiple Units to Evaluate the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus.

Who this might be right for
Systemic Lupus Erythematosus
Yipeng Liu 180
Testing effectiveness (Phase 2)UnknownNCT04629144
What this trial is testing

Efficacy and Safety of Belimumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Compared to Placebo. TRIBECA STUDY (Treatment nd BElimumab in Cryoglobulinemia Associated Vasculitis)

Who this might be right for
VasculitisCryoglobulinemia
Assistance Publique - Hôpitaux de Paris 48
Testing effectiveness (Phase 2)Study completedNCT00071812
What this trial is testing

A Safety and Efficacy Study of LymphoStat-B™ (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthritis (RA)

Who this might be right for
Arthritis, Rheumatoid
Human Genome Sciences Inc. 283
Large-scale testing (Phase 3)UnknownNCT05262686
What this trial is testing

Efficacy and Immunological Evaluation of Belimumab Plus Low Dose IL-2 in the Treatment of Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Peking University People's Hospital 10
Testing effectiveness (Phase 2)Study completedNCT01536379
What this trial is testing

Belimumab in the Prevention of Kidney Transplant Rejection

Who this might be right for
Transplantation, Organ
GlaxoSmithKline 30
Not applicableStudy completedNCT03501420
What this trial is testing

Adelphi Primary Sjogren's Syndrome (pSS) Disease Specific Programme (DSP)

Who this might be right for
Sjogren's Syndrome
GlaxoSmithKline 2,223
Not applicableUnknownNCT05358652
What this trial is testing

Precision Medicine in LN: A Multicenter Proof-of-concept Study for Histopathological Biomarkers Analysis in Renal Biopsy

Who this might be right for
Lupus NephritisSystemic Lupus Erythematosus
Fundacin Biomedica Galicia Sur 60
Testing effectiveness (Phase 2)Study completedNCT02124798
What this trial is testing

A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 95
Post-approval studies (Phase 4)Study completedNCT01705977
What this trial is testing

Belimumab Assessment of Safety in SLE

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 4,019
Post-approval studies (Phase 4)Study completedNCT04515719
What this trial is testing

Efficacy and Safety of Belimumab in SLE Patients

Who this might be right for
Systemic Lupus Erythematosus
RenJi Hospital 231
Testing effectiveness (Phase 2)Study completedNCT01670565
What this trial is testing

Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Hospital for Special Surgery, New York 20
Not applicableUnknownNCT05585671
What this trial is testing

Belimumab In Prevention of LN

Who this might be right for
Whether Belimumab Could Reduce 2-year Risk of New-onset Lupus Nephritis
RenJi Hospital 48
Testing effectiveness (Phase 2)Ended earlyNCT00583557
What this trial is testing

A Continuation Trial for Subjects With Rheumatoid Arthritis That Have Completed Protocol LBRA01

Who this might be right for
Rheumatoid Arthritis
Human Genome Sciences Inc. 155
Large-scale testing (Phase 3)Study completedNCT02347891
What this trial is testing

Belimumab in Idiopathic Inflammatory Myositis

Who this might be right for
Myositis
Northwell Health 17
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation